NCT02959060View on ClinicalTrials.gov

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Thrombosis
Interventions
DRUG

BMS-986177

Single dose of BMS-986177 and multiple doses of Rifampin

DRUG

Rifampin

Single dose of BMS-986177 and multiple doses of Rifampin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY